Journals / Nöropsikiyatri Arşivi / 2018 / Cilt: 55 - Sayı: 2

Clinical Features of Cancer Associated Ischemic Stroke

Kanserle İlişkili İskemik İnmenin Klinik Özellikleri

Pages
113–117
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Lacunar andposterior circulation syndromes were less common and total anteriorcirculation syndrome was more common in cancer patients (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Cerebrovascular disease is the second most commoncause of central nervous system involvement in cancer patients aftermetastases.
📊
Key Findings & Data:Procoagulant substances secreted by tumour cells, cancertherapy, and embolus from tumour have been implicated in ischemicstroke (IS) in cancer patients.Methods: Four thousand twenty patients with IS were prospectivelyrecorded to the Istanbul Medical School Stroke Registry from August1997 to May 2016.
💡
Conclusion & Impact:Lacunar andposterior circulation syndromes were less common and total anteriorcirculation syndrome was more common in cancer patients (p
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Cerebrovascular disease is the second most commoncause of central nervous system involvement in cancer patients aftermetastases. Procoagulant substances secreted by tumour cells, cancertherapy, and embolus from tumour have been implicated in ischemicstroke (IS) in cancer patients.Methods: Four thousand twenty patients with IS were prospectivelyrecorded to the Istanbul Medical School Stroke Registry from August1997 to May 2016. Ninety-two patients with IS and cancer and 3928 ISpatients without cancer constituted the two groups.Results: Hypertension, hyperlipidemia, and congestive heart failurewere less commonly encountered in cancer stroke patients. Lacunar andposterior circulation syndromes were less common and total anteriorcirculation syndrome was more common in cancer patients (p

Özet

Amaç: Serebrovasküler hastalık, kanser hastalarında metastazlardan sonra ikinci en sık merkezi sinir sitemi tutulumudur. Kanserli iskemik inme hastalarında, tümör hücrelerinden salınan prokoagülan maddeler, kanser tedavisi ve tümör embolisi gibi mekanizmalarla inme geliştiği düşünülmektedir. Yöntem: İskemik inmeli 4020 hasta Ağustos 1997 – Mayıs 2016 arasında İstanbul Tıp Fakültesi İnme Veri Bankası’na prospektif olarak kaydedilmiştir. Çalışmada incelenen iki grubu, kanseri olan 92 ve olmayan 3928 iskemik inmeli hasta oluşturmuştur. Bulgular: Kanserli iskemik inme hastalarında, hipertansiyon, hiperlipidemi ve konjestif kalp yetersizliği daha az saptanmıştır. Kanserli hastalarda, laküner ve arka sistem sendromu inmeleri daha az, total anterior sirkülasyon sendromu daha fazla görülmüştür (p

🔖

Cite This Article

EKİZOĞLU, E., YEŞİLOT, N., ÇOBAN, O. (2022). Clinical Features of Cancer Associated Ischemic Stroke. Nöropsikiyatri Arşivi, Cilt: 55 - Sayı: 2, 113–117. https://ajindex.com/articles/584699

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Haller S, Lyrer PA. Malignancy and Stroke. Semin Cerebrovasc Dis Stroke 2005;5:47–54. [CrossRef] Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a review. Acta Neurol Scand 2009;119:1–16. [CrossRef] Aarnio K, Joensuu H, Haapaniemi E, Melkas S, Kaste M, Tatlisumak T, Putaala J. Cancer in young adults with ischemic stroke. Stroke 2015;46:1601–1606. [CrossRef] Yesilot NF, Koyuncu BA, Coban O, Tuncay R, Bahar SZ. Gender differences in acute stroke: Istanbul medical school stroke registry. Neurol India 2011;59:174–179. [CrossRef] Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K, Vessey M, Fowler G, Molyneux A, Hughes T. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981–1986 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988;51:1373–1380.
  2. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
  3. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327–1330.
  4. Kono T, Ohtsuki T, Hosomi N, Takeda I, Aoki S, Sueda Y, Ishihara K, Nakamura T, Yamawaki T, Matsumoto M. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer. Geriatr Gerontol Int 2012;12:468–474. [CrossRef] Del Conde I, Bharwani LD, Dietzen DJ, Pendurthi U, Thiagarajan P, Lopez JA. Microvesicle-associated tissue factor and Trousseau’s syndrome. J Thromb Haemost 2007;5:70–74. [CrossRef] Kim SG, Hong JM, Kim HY, Lee J, Chung PW, Park KY, Kim GM, Lee KH, Chung CS, Bang OY. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke 2010;41:798– 801. [CrossRef] Kwon HM, Kang BS, Yoon BW. Stroke as the first manifestation of concealed cancer. J Neurol Sci 2007;258:80–83. [CrossRef] Sun B, Fan S, Li Z, Guo W, Liu L, Zhou Y, Ji L, Zhang L, Huang X. Clinical and Neuroimaging Features of Acute Ischemic Stroke in Cancer Patients. Eur Neurol 2016;75:292